Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-24-022023

Chief Executive Officer gave up 8,684 shares (to pay taxes)

  • Chief Executive Officer acquired 24,476 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Robinson Chandler · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-06-30 Exercise or conversion : show line 1 in the form +24,476 274,606.8 D
2024-06-30 Shares withheld for taxes : show line 2 in the form −8,684 $0.73 $6,348 265,922.8 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −24,476 173,335 D
Loading xslF345X05/rdgdoc.xml…